Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Baker Department of Cardiovascular Research, Translation and Implementation, La Trobe University, Melbourne, Victoria, Australia.
Diabetes Obes Metab. 2024 Dec;26(12):5690-5700. doi: 10.1111/dom.15938. Epub 2024 Sep 13.
To conduct a systematic review in order to better understand the association of glycaemic risk factors and diabetes duration with risk of heart failure (HF) in individuals with type 2 diabetes (T2D).
We identified longitudinal studies investigating the association of glycaemic factors (glycated haemoglobin [HbA1c], HbA1c variability, and hypoglycaemia) and diabetes duration with HF in individuals with T2D. Hazard ratios and odds ratios were extracted and meta-analysed using a random-effects model where appropriate. Risk of bias assessment was carried out using a modified Newcastle-Ottawa Scale. Egger's test along with the trim-and-fill method were used to assess and account for publication bias.
Forty studies representing 4 102 589 people met the inclusion criteria. The risk of developing HF significantly increased by 15% for each percentage point increase in HbA1c, by 2% for each additional year of diabetes duration, and by 43% for having a history of severe hypoglycaemia. Additionally, variability in HbA1c levels was associated with a 20%-26% increased risk of HF for each unit increase in the metrics of variability (HbA1c standard deviation, coefficient of variation, and average successive variability). All included studies scored high in the risk of bias assessment. Egger's test suggested publication bias, with trim-and-fill analyses revealing a significant 14% increased risk of HF per percentage point increase in HbA1c.
Glycaemic risk factors and diabetes duration significantly contribute to the heightened risk of HF among individuals with T2D. A reduction in risk of HF is anticipated with better management of glycaemic risk factors.
进行系统评价,以便更好地了解血糖风险因素和糖尿病病程与 2 型糖尿病(T2D)个体心力衰竭(HF)风险之间的关系。
我们确定了纵向研究,调查了血糖因素(糖化血红蛋白[HbA1c]、HbA1c 变异性和低血糖)和糖尿病病程与 T2D 个体 HF 之间的关系。提取了危险比和比值比,并在适当的情况下使用随机效应模型进行了荟萃分析。使用改良的 Newcastle-Ottawa 量表进行了偏倚风险评估。Egger 检验和填充法用于评估和考虑发表偏倚。
有 40 项研究代表了 4102589 人符合纳入标准。HbA1c 每增加 1%,HF 的发病风险增加 15%,糖尿病病程每增加 1 年,HF 的发病风险增加 2%,有严重低血糖史的 HF 发病风险增加 43%。此外,HbA1c 水平的变异性每增加一个单位,HF 的风险增加 20%-26%,变异性的度量(HbA1c 标准差、变异系数和平均连续变异性)也与 HF 的风险增加相关。所有纳入的研究在偏倚风险评估中得分较高。Egger 检验提示存在发表偏倚,填充法分析显示,HbA1c 每增加 1%,HF 的风险显著增加 14%。
血糖风险因素和糖尿病病程显著增加了 T2D 个体 HF 的风险。通过更好地管理血糖风险因素,可以预期 HF 的风险降低。